Cargando…

Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study

Objectives: To investigate whether medication regimen complexity and/or polypharmacy are associated with all-cause mortality in older people. Methods: This was a population-based cohort study among community-dwelling and institutionalized people ≥60 years old (n = 3348). Medication regimen complexit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wimmer, Barbara C., Bell, J. Simon, Fastbom, Johan, Wiese, Michael D., Johnell, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714103/ https://www.ncbi.nlm.nih.gov/pubmed/26681444 http://dx.doi.org/10.1177/1060028015621071

Ejemplares similares

Medication Regimen Complexity and Number of Medications as Factors Associated With Unplanned Hospitalizations in Older People: A Population-based Cohort Study
por: Wimmer, Barbara Caecilia, et al.
Publicado: (2016)

The epidemiology of polypharmacy in older adults: register-based prospective cohort study
por: Morin, Lucas, et al.
Publicado: (2018)

The composition of polypharmacy: A register-based study of Swedes aged 75 years and older
por: Wastesson, Jonas W., et al.
Publicado: (2018)

Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people
por: Johnell, Kristina, et al.
Publicado: (2009)

Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020
por: Wastesson, Jonas W., et al.
Publicado: (2023)

National Indicators for Quality of Drug Therapy in Older Persons: the Swedish Experience from the First 10 Years
por: Fastbom, Johan, et al.
Publicado: (2015)

The impact of dementia on drug costs in older people: results from the SNAC study
por: Sköldunger, Anders, et al.
Publicado: (2016)

Impact of Inappropriate Drug Use on Hospitalizations, Mortality, and Costs in Older Persons and Persons with Dementia: Findings from the SNAC Study
por: Sköldunger, Anders, et al.
Publicado: (2015)

Dose–Response Relationships Between Polypharmacy and All-Cause and Cause-Specific Mortality Among Older People
por: Huang, Yun-Ting, et al.
Publicado: (2021)

Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults
por: Johnell, Kristina, et al.
Publicado: (2016)

Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
por: Wallerstedt, Susanna M., et al.
Publicado: (2013)

Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life
por: Grande, Giulia, et al.
Publicado: (2017)

Use of potentially inappropriate medication and polypharmacy in older adults: a repeated cross-sectional study
por: Thorell, Kristine, et al.
Publicado: (2020)

Use of Fall-Risk Inducing Drugs in Patients Using Anti-Parkinson Drugs (APD): A Swedish Register-Based Study
por: Haasum, Ylva, et al.
Publicado: (2016)

Socio-demographic differences in polypharmacy and potentially inappropriate drug use among older people with different care needs and in care settings in Stockholm, Sweden
por: Doheny, Megan, et al.
Publicado: (2021)

Socioeconomic inequalities in access to specialized psychotropic prescribing among older Swedes: a register-based study
por: Wastesson, Jonas W., et al.
Publicado: (2014)

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
por: Morin, Lucas, et al.
Publicado: (2018)

Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe
por: Midão, Luís, et al.
Publicado: (2021)

How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study
por: Morin, Lucas, et al.
Publicado: (2019)

Factors associated with excessive polypharmacy in older people
por: Walckiers, Denise, et al.
Publicado: (2015)

Polypharmacy and injurious falls in older adults: a nationwide nested case-control study
por: Morin, Lucas, et al.
Publicado: (2019)

Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older
por: Wastesson, Jonas W., et al.
Publicado: (2016)

Determination of a cutoff value for medication regimen complexity index to predict polypharmacy in HIV+ older patient
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2019)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

The association between polypharmacy and medication regimen complexity and antibiotic use in bronchiectasis
por: Spargo, Maureen, et al.
Publicado: (2018)

Psychosocial job strain and polypharmacy: a national cohort study
por: Tan, Edwin CK, et al.
Publicado: (2020)

The Need for Actions Against Polypharmacy in Older People With Frailty
por: Kojima, Taro
Publicado: (2018)

Association between Multi-Dose Drug Dispensing and Quality of Drug Treatment – A Register-Based Study
por: Sjöberg, Christina, et al.
Publicado: (2011)

Hematological parameters and all-cause mortality: a prospective study of older people
por: Frąckiewicz, Joanna, et al.
Publicado: (2017)

Dopaminergic and Serotonergic Drug Use: A Nationwide Register-Based Study of Over 1 300 000 Older People
por: Johnell, Kristina, et al.
Publicado: (2011)

Polypharmacy in Older People With Heart Failure: Roles of the Geriatrician and Pharmacist
por: Stefil, Maria, et al.
Publicado: (2022)

Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality
por: Mitnick, Carole D., et al.
Publicado: (2013)

Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice
por: Francesca, Eroli, et al.
Publicado: (2021)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Frailty Status and All-Cause Mortality in the Community-Dwelling Older People: An Umbrella Review
por: Ekram, A R M Saifuddin, et al.
Publicado: (2020)

Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study
por: Ding, Mozhu, et al.
Publicado: (2018)

Polypharmacy and medical intensive care unit (MICU) admission and 10-year all-cause mortality risk among hospitalized patients with and without HIV
por: Gordon, Kirsha S., et al.
Publicado: (2022)

Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis
por: Iqbal, Anum, et al.
Publicado: (2023)

Prevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy
por: Wurmbach, Viktoria S., et al.
Publicado: (2022)

Polypharmacy among HIV infected people aged 50 years or older
por: Fernández Cañabate, Sonia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i1c1lk42q2ilcquot7c2iuru9t